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Introduction {#sec1}
============

The prevalence of infections by opportunistic pathogens (i.e., candidiasis) is increasing, partly owing to recent medical progress enabling the survival of susceptible individuals \[[@bib1]\]. Main prevalent agents of candidiasis comprise three *Candida* species: *Candida albicans*, *Candida glabrata*, and *Candida parapsilosis*, generally in this order \[[@bib2]\]. Phylogenetically, these species are only distantly related. *C. glabrata* belongs to the *Nakaseomyces* clade, a group that is more closely related to the baker's yeast *Saccharomyces cerevisiae* than to *C. albicans* or *C. parapsilosis* \[[@bib3]\]. Furthermore, both *C. glabrata* and *C. albicans* have closely related non-pathogenic relatives, and hence the ability to infect humans in these two lineages must have originated independently \[[@bib4], [@bib5]\]. Genome sequencing of non-pathogenic and mildly pathogenic relatives of *C. glabrata* has enabled tracing the genomic changes that correlate with the evolutionary emergence of pathogenesis in the *Nakaseomyces* group \[[@bib3]\]. These analyses revealed that the ability to infect humans has most likely emerged at least twice independently in the *Nakaseomyces*, coinciding with parallel expansions of the encoded repertoire of cell-wall adhesins. Thus, increased---or more versatile---adherence may be implicated in the evolutionary emergence of virulence potential toward humans. In contrast, other virulence-related characteristics had a more ancient origin within the clade, and were also found in environmental relatives.

Our understanding of the evolution of *C. glabrata* at the species level is limited to analyses of natural variation in a few loci \[[@bib6], [@bib7], [@bib8]\]. These studies have shown the existence of genetically distinct clades and generally suggested clonal, geographically structured populations. Geographically structured populations are also found in *C. albicans*, which is tightly associated with humans and which can undergo a parasexual cycle \[[@bib9], [@bib10], [@bib11]\], and *S. cerevisiae*, for which some strains have been domesticated and which can undergo a full sexual cycle, usually involving self-mating \[[@bib12], [@bib13]\]. *C. glabrata* has been described as an asexual species despite the presence of homologs of *S. cerevisiae* genes involved in mating \[[@bib14]\]. Here we undertook a genomics approach to shed light on several fundamental open questions on the recent evolution of this important opportunistic pathogen: namely (1) what is the genetic structure of the global *C. glabrata* population? (2) Does *C. glabrata* show patterns of co-evolution with human populations indicating an ancient association? (3) Is there evidence for active mating and mating-type switching systems in this species? (4) How dynamic is the *C. glabrata* genome and how does it underlie phenotypic diversity across strains? In order to answer these questions, we analyzed the genomes and phenotypes of 33 different clinical and colonizing *C. glabrata* isolates sampled from different human body sites and globally distributed locations, and chosen within genotyped collections in order to be representative of the previously explored population structure \[[@bib8], [@bib15]\] ([Table 1](#tbl1){ref-type="table"}). This sampling includes the extensively studied BG2 strain, as well as three pairs of strains, each isolated from a single patient.Table 1Information About the 33 *C. glabrata* Isolates Analyzed in the Present Study, Including the Reference CBS138Sample IDSynonymous IDMean CoverageSiteCountryMating TypeCCRTSource DataBG2US01BG2Blo84.192bloodUSA**a**1515\[[@bib16]\]CST34US000NY034476.944bloodUSAalpha6464\[[@bib8]\]CST35US003NY035489.168bloodUSAalpha7777\[[@bib8]\]E1114EB1114Mou120.349mouthBelgium**a**1515\[[@bib15]\]EB0911Sto−339.156stoolBelgiumalpha7794\[[@bib15]\]EF0616Blo1−261.098bloodFrance**a**5252\[[@bib8]\]EF1237Blo1−301.835bloodFrance**a**5252\[[@bib8]\]EF1620Sto−285.374stoolFrance**a**5298\[[@bib15]\]EI1815Blo1−301.624bloodItalyalpha5252\[[@bib8]\]EG01004Sto−262.568stoolGermany**a**1517\[[@bib15]\]F03013EF0313Blo1340.021bloodFrance**a**1513\[[@bib8]\]F11F11017, EF1117Blo169.306bloodFrance**a**NA88\[[@bib17]\]F15021EF1521Blo1116.500bloodFrance**a**1515\[[@bib8]\]F15F15035, EF1535Blo180.737bloodFrance**a**4141\[[@bib17]\]M17US02Bal017121.681bloodUSA**a**66\[[@bib8]\]P35_2P35-2285.029mouthTaiwan**a**NA106\[[@bib18]\]P35_3P35-3245.637mouthTaiwanalphaNA106\[[@bib18]\]B1012M[a](#tblfn1){ref-type="table-fn"}EB1012MouC302.046mouthBelgiumalphaNA103\[[@bib15]\]B1012S[a](#tblfn1){ref-type="table-fn"}EB1012StoC240.391stoolBelgiumalpha64102\[[@bib15]\]BO101S[a](#tblfn1){ref-type="table-fn"}EB0101StoC312.022stoolBelgiumalpha64104\[[@bib15]\]CST109US003NY109294.590bloodUSAalpha6466\[[@bib8]\]CST110US003NY110235.403bloodUSA**a**1515\[[@bib8]\]CST78US003NY078266.426bloodUSA**a**68\[[@bib8]\]CST80US003NY080241.972bloodUSAalpha6464\[[@bib8]\]EB101M[a](#tblfn1){ref-type="table-fn"}EB0101MouC300.099mouthBelgiumalpha64104\[[@bib15]\]F1019EF1019Blo1274.760bloodFrance**a**66\[[@bib8]\]F1822EF1822Blo1291.361bloodFrance**a**610\[[@bib8]\]F2229EF2229Blo1652.126bloodFrance**a**67\[[@bib8]\]I1718EI1718Blo1217.526bloodItaly**a**65\[[@bib8]\]M12US02Bal012268.030bloodUSAalpha611\[[@bib8]\]M6US02Bal006247.431bloodUSA**a**1515\[[@bib8]\]M7US02Bal007314.610bloodUSAalpha6465\[[@bib8]\]CBS138ATCC 2001NAstoolBelgiumalphaNA62\[[@bib19]\][^2][^3]

By using genome-wide information on these 33 strains, we assessed the levels of genetic variation to infer the population structure of *C. glabrata*, its recent evolution, and its genomic plasticity. In addition, given the current consideration of *C. glabrata* as an asexual species despite the presence of the entire mating genetic toolkit, we used our dataset to search for evidence of mating at the genomic level. In order to do so, we looked for genomic footprints of recombination and mating-type switching, and we evaluated whether mating genes are under purifying or relaxed selection. Finally, we performed experiments to assess whether the observed genomic plasticity is reflected at the phenotypic level.

Results and Discussion {#sec2}
======================

High Levels of Genetic Diversity between Clades and Lack of Strong Geographical Structure {#sec2.1}
-----------------------------------------------------------------------------------------

To characterize the genomic variability in the 33 studied strains of *C. glabrata*, we cataloged single-nucleotide polymorphisms (SNPs) and copy-number variations (CNVs) ([STAR Methods](#sec3){ref-type="sec"}) using a read-mapping strategy against the available reference genome \[[@bib19]\]. Overall, we detected a range of 4.66--6.56 SNPs/kb per strain when compared to the reference, 0.04--7.23 SNPs/kb between pairs of strains from different patients, and 0.05--0.07 SNPs/kb between strains isolated from the same patient. The low variability between strains of the same individual is indicative that patients were colonized by a single strain that subsequently dispersed to different body sites. We used multiple correspondence analysis (MCA), maximum-likelihood (ML) phylogenetic reconstruction, and model-based clustering to establish the main relationships between all sequenced strains ([Figure 1](#fig1){ref-type="fig"}). Overall, these analyses support the existence of seven major clades, hereafter referred to as clade I through clade VII. Previous studies also classified different strains of *C. glabrata* in clades based on multilocus sequence typing (MLST) \[[@bib6], [@bib7]\]. We compared the topologies of strain phylogenies reconstructed from MLST or whole-genome data using the same set of strains. The two topologies overlap to a large extent but there are notable differences with respect to the relationships between clades ([Figure S1](#mmc1){ref-type="supplementary-material"}). Notably, our model-based clustering of genetic variation suggested the existence of genetic admixture between different clades (particularly between clades I and II, IV and V, and V--VII). Phylogenetic reconstruction and fixation indices (F~ST~s) indicate that most clades diverged deeply within the *C. glabrata* lineage. Genetic distance between the two most distant clades (clade I and clade VII, 6.59--7.22 SNPs/kb) is only slightly higher than that between the most closely related ones (clade I, clade II, and clade III; 4.48--6 SNPs/kb), but up to two orders of magnitude larger than the amount of genetic divergence within clades (0.03--0.29 SNPs/kb for all clades except clade V, with 4.37--4.68 SNPs/kb). Comparatively, the level of variation between distant *C. glabrata* clades is higher than the amount of genetic variation among distant clades in human-associated *C. albicans* (average of 3.7 SNPs/kb) \[[@bib10]\]. Most clades were present across distant locations and in different body sites, but they were generally enriched in one of the two mating types ([Figure 1](#fig1){ref-type="fig"}; [Figure S2](#mmc1){ref-type="supplementary-material"}A).Figure 1Population Structure of the 33 Strains of *C. glabrata*Distribution and population structure of the 33 strains of *C. glabrata* based on SNP data analysis.(A) 3D scatterplot of the multiple correspondence analysis (MCA), in which the different colors designate the seven clades detected.(B) Phylogenetic tree computed using a ML approach. Super-indices indicate pairs of strains in which the two originate from the same patient (different body site or different isolation date; see [Table 1](#tbl1){ref-type="table"} for more details). Clades from I to VII were designated using the same colors as in (A).(C) Population admixture using STRUCTURE software with K = 7 using the same colors as in (A).(D) Mean F~ST~ for all pairwise comparisons between the seven clades. Fisher test was used to analyze the association with geographical structure (p(country-clade) = 0.006), body site of isolation (p(site-clade) = 0.157), and mating type (p(mating-clade) = 6.064e-05).See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

After these analyses were performed, several other studies reported the sequences of 20 additional strains \[[@bib20], [@bib21], [@bib22]\]. To confirm the representativeness of our dataset, we repeated the population structure analyses on an expanded dataset of 53 strains, which include these 20 additional strains ([Figure S2](#mmc1){ref-type="supplementary-material"}B). All the new strains clustered within our already delimited clades, indicating that they cover a large fraction of the diversity of *C. glabrata* clinical isolates. Of note, we observed that in the expanded dataset clade IV and clade V merged, justifying our previously discussed low F~ST~ values between these two clades. Importantly, the expanded dataset includes the pyruvate-producing strain *C. glabrata* CCTCC M202019 \[[@bib20]\]. The parental of this strain has been isolated from fertile soil \[[@bib23]\], and thus it represents the only available genome sequence from a strain not isolated from the human body. Our re-analysis of this strain (see [STAR Methods](#sec3){ref-type="sec"}) identifies relatively few SNPs when compared against the reference CBS138 (1,026 SNPs, 0.08 SNPs/kb), which situates this strain within clade V and as the most similar to the reference genome. Altogether, the current lack of a strong geographical structure of deeply divergent clades suggests recent global migration of human-associated *C. glabrata* strains. Finally, the appearance of a strain isolated from soil within a clade of human-associated strains suggests that strains with similar genetic backgrounds can colonize humans and the environment. Alternatively, this strain could actually represent a recent colonization of soil from a human source.

Genome Plasticity in *C. glabrata*: Extensive CNV and Presence of Aneuploidies and Re-arrangements {#sec2.2}
--------------------------------------------------------------------------------------------------

To evaluate the plasticity of the *C. glabrata* genome, we estimated the number of deletions and duplications in the 33 strains, using depth-of-coverage analyses (see [STAR Methods](#sec3){ref-type="sec"}). Overall, we detected a total of 46 deleted and 62 duplicated genes ([Figure 2](#fig2){ref-type="fig"}; [Data S1](#mmc7){ref-type="supplementary-material"}). Of these, we experimentally confirmed a deletion covering three genes (see [Figure S3](#mmc1){ref-type="supplementary-material"}). A significant fraction of the deleted (45.65%) or duplicated (41.94%) genes encoded glycosylphosphatidylinositol (GPI)-anchored adhesin-like proteins, as compared to the 1.3% that this functional category represents over the entire genome \[[@bib24]\]. Taken together, analysis of biallelic SNPs, flow cytometry, and electrophoretic karyotyping indicate that all analyzed strains are haploid, albeit with variations in total DNA content and chromosome numbers and lengths ([Figure S4](#mmc1){ref-type="supplementary-material"}). Depth-of-coverage analysis revealed aneuploidies involving a whole duplication of chromosome E, whose presence is interspersed in different clades, and one strain carrying a partial aneuploidy of chromosome G ([Figure 2](#fig2){ref-type="fig"}; [Figure S5](#mmc1){ref-type="supplementary-material"}A). Aneuploid chromosomes had similar numbers of predicted heterozygous SNPs as other chromosomes when a diploid model was enforced in the SNP calling process ([Figure S5](#mmc1){ref-type="supplementary-material"}B; see [STAR Methods](#sec3){ref-type="sec"}), suggesting the extra chromosomes diverged recently. Although all aneuploidies affect genes related to drug resistance, the aneuploid strains had normal sensitivity to tested antifungals (see below). Interestingly, our sequencing data indicated that a major duplication of chromosome J occurred spontaneously while growing one strain (F2229) in rich medium and in the absence of antifungals, as it was present only in about 50% of the cells at the time of sequencing (see [Figure S5](#mmc1){ref-type="supplementary-material"}C). This underscores the plasticity of the *C. glabrata* genome even under laboratory conditions \[[@bib25]\]. Karyotypes for each strain, assessed using pulsed-field gel electrophoresis (PFGE), revealed important variations in chromosome numbers and sizes ([Figure S4](#mmc1){ref-type="supplementary-material"}B). We next assembled *de novo* and annotated the genomes for all the newly sequenced strains. Alignments of the newly sequenced strains with the reference revealed 20 different large re-arrangements grouped in 17 conformations and affecting 26 different strains, including 14 translocations and 3 inversions ([Figure 3](#fig3){ref-type="fig"}), some of which confirmed previous reports based on electrophoretic karyotyping and comparative genome hybridization \[[@bib17]\].Figure 2Structural Variations in the Analyzed Strains of *C. glabrata*Heatmap showing the deletions, duplications, and aneuploidies (Anpl.) detected in the analyzed strains of *C. glabrata* sorted by clade. Reference (CBS138) and chromosomes with aneuploidies in affected strains (see below) or genomes with unstable coverage are not shown. The heatmap at the top of the figure designates gene information: light gray, gray, and black represent genes in a tandem duplication (T), orphan genes (O), and genes encoding GPI-anchored adhesin-like proteins (A), respectively. The heatmap colored in green designates the 46 genes affected by deletions, and the heatmap colored in red designates the 62 genes affected by duplications. Aneuploidies are indicated with a light gray background with the letter of the chromosome affected. Fisher test was used to test the significant enrichment in genes encoding GPI-anchored adhesin-like proteins (p \< 1.4e-26 and 5.2e-31 in deletions and duplications, respectively), orphan proteins (p \< 0.051 and 0.436 in deletions and duplications, respectively), and genes in a tandem duplication (p \< 1.5e-09 and 3.0e-05 in deletions and duplications, respectively). See [Data S1](#mmc7){ref-type="supplementary-material"} for the complete list of genes affected.See also [Figures S3--S5](#mmc1){ref-type="supplementary-material"}.Figure 3Chromosomal Re-arrangements(A) Diagram showing the 20 different large re-arrangements found in *C. glabrata*. Re-arrangements are grouped in 17 different conformations, including 14 translocations and 3 inversions. Chromosomes are indicated in letters from A to M and each one in a different color. Re-arrangement in a chromosome is indicated with the colors of the chromosomes affected. Arrows near the inversion plots indicate the relative orientation of the indicated fragments.(B) Heatmap showing the distribution of annotated re-arrangements (1--20) and the 26 affected strains. Asterisks indicate strains not included in the analysis due to high fragmentation of the assembly.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

We next compared all genomes in terms of their protein-coding content, using a gene similarity-based clustering approach, excluding four strains whose assemblies were deemed of low quality (see [STAR Methods](#sec3){ref-type="sec"}). We found that 580 protein-coding genes from the reference strain (CBS138) are unique to this genome. Similarly, a range of 302--580 predicted genes (average 342) are unique for each strain, totaling 9,915 strain-specific genes among the 29 strains considered. Although most of these genes are most likely the result of spurious automated annotations or artifacts from the clustering approach, some may constitute recently emerged genes. 3,603 protein-coding gene clusters are present in all analyzed strains. Given the likely incompleteness of the *de novo* assemblies, we consider this a lower bound to the *C. glabrata* core genome. Widespread genes, present in at least 20 of the 29 considered genomes, comprised 4,726 gene clusters. The remaining 252 gene clusters, which comprise 32 genes in CBS138, had more restricted distributions, being present in 2--19 *C. glabrata* strains, and often being clade specific.

Evidence for Genomic Recombination between Distinct Clades {#sec2.3}
----------------------------------------------------------

As mentioned above, model-based clustering of genetic variation provided indication of genetic admixture between different clades. In particular, individuals of clade II may have undergone extensive recombination with clade I, as indicated by the presence of large interspersed regions without SNPs when comparing pairwise differences in SNP density ([Figure 4](#fig4){ref-type="fig"}A). The presence of these regions is indicative of recombination, because under a scenario of shared ancestral variation we would expect to find this shared variation dispersed across the genome and not organized in large blocks, as is the case. We estimated recombination rates (rho = 2Ner for haploid species) between pairs of SNPs in each chromosome ([Figure 4](#fig4){ref-type="fig"}B; [Figure S6](#mmc1){ref-type="supplementary-material"}). Despite overall low mean values (ranging from 0.008 to 0.003), we found evidence of recombination in all chromosomes, and a quite heterogeneous distribution both between and within chromosomes. We also used fastGEAR software to elucidate whether recombination predates the diversification of strains within a clade (i.e., ancestral) or is subsequent to it (i.e., recent) ([Figure 4](#fig4){ref-type="fig"}C). This software first classifies the strains in lineages and subsequently calculates the number of ancestral and recent recombination events and tests for their significance. Of note, when using all concatenated chromosomes, the software classified the strains in the same way as STRUCTURE (see above). Importantly, we consistently found that the levels of ancestral recombination are much higher than the recent, and the test of significance suggests that some degree of recent recombination is still occurring in all chromosomes. We also found several striking cases of deletions, and large re-arrangements that were shared between distantly related isolates ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}), despite the fact that, overall, the distribution of most CNVs and large-scale re-arrangements described above agreed with the defined clades. In a few cases, specific CNVs were found across individuals and populations and may be explained by shared ancestral variation. However, given the close correspondence of the predicted boundaries of some re-arrangements, we considered it unlikely that most of these patterns emerged independently, and suspected the existence of recombination events between distinct lineages. To further confirm the presence of recombination around CNVs shared between distant strains, we performed a detailed analysis of 19 such cases, estimating recombination rates and reconstructing phylogenetic networks (see [STAR Methods](#sec3){ref-type="sec"}). Seventeen out of 19 deletions showed a recombination rate higher than 0.05 (which is indicative of a recombination hotspot) or strains from different clades clustered together in the phylogenetic network, suggesting that those deletions are most likely the result of genetic exchange mediated through genomic recombination ([Figure 4](#fig4){ref-type="fig"}D). Overall, our results indicate that *C. glabrata* is still currently able to recombine, and that recombination impacts the genetic variation across chromosomes but also its structure. Finally, the finding of recombination between different strains necessarily implies the existence of some type of mating in *C. glabrata*.Figure 4Recombination Analyses(A) Profile of SNP densities obtained when comparing the genomes of strains in clade I and clade II using non-overlapping 10-kb windows along the entire genome. The bar at the top indicates the order and relative length of *C. glabrata* chromosomes in CBS138. The first profile indicates SNP density between the two strains from clade I (M7 versus B1012M). Second and third profiles indicate SNP density between EB0911Sto and CST35 from clade II versus clade I (using B1012M as a reference for this clade). The fourth profile indicates SNP density between the two strains of clade II. Boxes indicate regions without SNPs, which is indicative of recombination.(B) Distribution of the recombination rate (rho) across chromosomes, estimated from SNP data using the interval program implemented in the LDhat v2.2 package. For this figure, we selected chromosome A and chromosome B as an example (recombination rate 0.008 and 0.004, respectively). A complete illustration including all chromosomes is found in [Figure S6](#mmc1){ref-type="supplementary-material"}.(C) Visual representation of the population genetic structure and recombination events inferred by fastGEAR. The bar at the top indicates the order and relative length of *C. glabrata* chromosomes. We provide two panels corresponding to ancestral recombinations (occurred before the most recent common ancestor of both clusters) and recent recombinations (occurred after the diversification of the clusters). In each panel, the different colors designate each lineage; rows correspond to sequences and columns to positions.(D) Analysis of the region surrounding the deletion in *CAGL0C00847 g* gene is shown as an example. First, we selected regions containing the gene of interest and 1-kb flanking regions in the 33 strains. Second, we estimated recombination rates (rho/bp) in the selected regions and computed phylogenetic networks (see [STAR Methods](#sec3){ref-type="sec"}). Bottom left: plot showing recombination rates along the genomic region. Values higher than 0.05 indicate a recombination hotspot. Bottom right: NeighborNet splits network showing gene flow between strains and the phylogenetic signal in the region. Clades are indicated as dots of different colors, and the length of the edges is proportional to the weight of the associated split. Strains of different clades cluster together, suggesting a much closer genetic relationship than expected from the genome-wide analysis, which is indicative of recombination between different clades.

Genes Involved in Mating Are Evolutionarily Constrained at the Species Level {#sec2.4}
----------------------------------------------------------------------------

The above results suggest that mating does occur in *C. glabrata*. If mating has played a role in *C. glabrata* adaptation, we expect genes involved in mating to show hallmarks of selective constraints at the species level. We assessed levels of genetic variation using nucleotide diversity in *C. glabrata* genes, and compared these with those obtained from re-analyzing published data in *C. albicans* and *S. cerevisiae*, which show parasexual and sexual cycles, respectively (see [STAR Methods](#sec3){ref-type="sec"}; [Table S1](#mmc2){ref-type="supplementary-material"}). At the genome-wide level, the three species show overall similar levels of constraints ([Figure 5](#fig5){ref-type="fig"}A). We next focused on three different classes of genes involved in mating and recombination: (1) genes involved in the first steps of the sexual cycle \[[@bib14]\]; (2) genes involved in chromatin silencing of sexual genes and regulation of mating-type cassettes \[[@bib14]\]; and (3) genes involved in replication, repair, and recombination \[[@bib26]\] ([Figure 5](#fig5){ref-type="fig"}A). All three classes showed signatures of constraints in the three species. Of note, although some classes are more constrained than others, similar patterns are observed in all species. For instance, genes involved in meiotic recombination and repair had signs of relaxation of selection as compared to genes involved in other cellular processes (p = 2.7e−05), whereas genes involved in the sexual cycle are more constrained compared to *S. cerevisiae* and *C. albicans* (p = 0.009 and p = 4.3e−05, respectively). We searched for genes with nucleotide diversity higher than the one in *C. glabrata* as compared to *S. cerevisiae* and *C. albicans*, indicating an excess of non-synonymous variations ([Table S2](#mmc3){ref-type="supplementary-material"}). This uncovered the orthologs of *S. cerevisiae* genes *ESC1*, *MEI4*, *REC114*, and *RAD9*, which are involved in silencing, meiotic double-strand break formation, meiotic recombination, and DNA damage repair, respectively. Importantly, Esc1p interacts with Sir4p, which is involved in telomere silencing of the *HML* and *HMR* cassettes in *S. cerevisiae* \[[@bib27]\]. Altogether, our results show that *C. glabrata* genes involved in mating and meiosis have comparable levels of selective constraints as those found in *C. albicans* and *S. cerevisiae*, providing support for the existence of a sexual or parasexual cycle in *C. glabrata*. Of note, the anomalous excess of non-synonymous mutation in the *C. glabrata* ortholog *ESC1*, suggestive of a recent functional shift, may provide a clue for the observed differences in silencing of mating loci between *S. cerevisiae* and *C. glabrata* \[[@bib28]\].Figure 5Ratio of Non-synonymous and Synonymous Nucleotide Diversity and Mating-type Switching in *C. glabrata*(A) Ratio of non-synonymous and synonymous nucleotide diversity (π~N~/π~S~) in genes involved in mating and recombination in *C. glabrata*, and in their one-to-one orthologs in *C. albicans* and *S. cerevisiae*. Dark blue plots show overall π~N~/π~S~ values in each category, and light blue plots show specific groups of genes included in each category. The most distant outliers are not shown, as the length of the y axis was limited to 2. NHEJ, non-homologous end joining.(B) Organization of mating-type loci in *C. glabrata*: *MTL1* in white, *MTL2* in green, and *MTL3* in blue. *MTL1* is shown enlarged on the right, encoding either **a**- or alpha-type genes.(C) Diagram of the four cases of mating-type switching events likely to have occurred in sequenced strains. BS, before switching; AS, after switching; MMR, mismatch repair; NER, nucleotide excision repair.See also [Figure S7](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}.

Illegitimate Mating-type Switching {#sec2.5}
----------------------------------

Both the evidence of recombination and constraints detected in genes involved in mating support the existence of mating-type switching, albeit very limited, in *C. glabrata* populations, consistent with earlier observations \[[@bib8]\]. Similar to *S. cerevisiae*, the *C. glabrata* genome encodes the two mating types (**a** and alpha) in three different loci called *MTL1* (*MAT*), *MTL2* (*HMR*), and *MTL3* (*HML*), and the *HO* gene, which encodes the endonuclease responsible for gene conversion-based mating-type switching. *MTL2* and *MTL3* encode **a** and alpha information, respectively, and they are close to telomeres. The *MTL1* locus encodes either **a** or alpha, and this information determines the mating-type identity of the cell ([Figure 5](#fig5){ref-type="fig"}B). To unveil whether mating-type switching occurred in the studied strains, we analyzed in detail the mating-type loci. Our analysis revealed eight strains that present gene conversion events of four different types ([Figure 5](#fig5){ref-type="fig"}C; [Figure S7](#mmc1){ref-type="supplementary-material"}). In three cases, a normal conversion event at *MTL1* switched the mating type from **a** to alpha. The five remaining cases represent cases of aberrant conversions. In one case, **a**-to-alpha switching at *MTL1* is accompanied by illegitimate conversion at *MTL2*, resulting in a triple-alpha strain. In three cases, illegitimate *MTL2* conversion occurred in the apparent absence of *MTL1* switching. A final case represents illegitimate conversion of *MTL3* in the apparent absence of *MTL1* switching, leading to a triple-**a** strain. In all aberrant cases, the correspondence of the conversion track with an *HO* cutting site strongly suggests that this switching is mediated by illegitimate cuts in *MTL2* or *MTL3*. These results show that aberrant conversions, which had so far only been observed when induced experimentally \[[@bib28], [@bib29]\], can occur in natural populations.

Genomic Plasticity Enables Large Phenotypic Differences between and within Clades {#sec2.6}
---------------------------------------------------------------------------------

To assess whether the observed genomic plasticity was reflected at the phenotypic level, we measured several relevant phenotypes of the sequenced strains. Specifically, we tested biofilm formation properties and antifungal drug susceptibility, and measured growth under stress conditions such as high and low pH, high temperature, and presence of DTT, sodium chloride, or hydrogen peroxide (see [STAR Methods](#sec3){ref-type="sec"}, [Figure 6](#fig6){ref-type="fig"}, and [Table S3](#mmc4){ref-type="supplementary-material"}). Most conditions showed important differences between some strains of the same clade ([Figure 6](#fig6){ref-type="fig"}). In fact, for most conditions and most clades, intra-clade variation was of a similar range as inter-clade variation ([Figures 6](#fig6){ref-type="fig"}A and 6C). Using the R package Growthcurver, we obtained a table with the main growth curve parameters ([Table S3](#mmc4){ref-type="supplementary-material"}). A principal component analysis using those values showed that clades do not cluster by phenotype, underscoring the high phenotypic plasticity even within a similar genetic background ([Figure 6](#fig6){ref-type="fig"}B). We next surveyed private mutations, that is, SNPs and CNVs present in a single strain of a clade ([Data S2](#mmc8){ref-type="supplementary-material"}). This resource may help to identify the genetic bases of phenotypic differences in strains behaving drastically different from their close relatives, as well as identifying common mutations in distant strains that show similar behaviors in a given condition. Three strains (M6, M7, and M17) showed reduced sensitivity to one or more antifungal drugs, among eight tested ([Table S4](#mmc5){ref-type="supplementary-material"}). Each carried a unique, private mutation in *PDR1* (leading to amino acid exchanges I390K in M6, I378T in M7, and N306S in M17), a known regulator of pleiotropic drug response \[[@bib31]\]. Recently, it has been claimed that prevalent mutations in the mismatch repair gene *MSH2* found in clinical isolates promote drug resistance through a mutator phenotype \[[@bib32]\]. Fifteen (45%) of the 33 analyzed strains carry non-synonymous SNPs in that gene, which include only one (M17) of the three strains with reduced antifungal susceptibility. These 15 strains carried four different *MSH2* variants, of which two correspond to variants previously proposed to be loss-of-function mutator genotypes (V239L/A942T and V239L). However, these SNPs were shared by all strains in the same clade and correspond to fixed mutations in other yeast species, and strains with these genotypes did not show unusual patterns of non-synonymous or synonymous variations (see [Table S5](#mmc6){ref-type="supplementary-material"}). Altogether, our results suggest that these mutations represent natural genetic variation and are most likely not related to a mutator phenotype. We next focused on differences in adherence properties, a virulent trait that may vary depending on the repertoire of proteins attached to the cell wall. We noted that three strains showed high (F03013) or moderately high (CST35 and F15021) ability to form biofilm on polystyrol ([Figure 6](#fig6){ref-type="fig"}D). These three biofilm-forming strains shared independent duplications of *PWP4* and deletions of *AWP13*, two GPI-anchored adhesins \[[@bib24]\]. Although these and other genotype-phenotype relationships enabled by the current dataset can provide useful hints, further experiments are needed to assess what genomic alterations underlie a given phenotypic variation.Figure 6Phenotype Analysis Testing the Growth Rate Using Seven Different Conditions(A) Growth curves for the 7 different conditions. The first condition was YPD as a normal medium for growth. Following conditions were H~2~O~2~, NaCl, DTT, high temperature (41.5 T°), basic pH (pH 9), and acid (pH 2). Unless indicated otherwise, all growth curves were carried out at 37°C. The y axis shows the optical density (OD) for each clade, and the x axis shows time (in hours).(B) Principal component analysis (PCA) showing the relationship between the statistics values for the growth curves and the distribution of the strains.(C) Heatmap with growth rate value (r) for all strains and normalized values with the growth rate from the reference strain.(D) Results represent the averages of three independent replicas of four technical repeats each. Positive controls are well-characterized clinical isolates from urine and respiratory material, respectively, with known high-adherence phenotypes \[[@bib30]\]. Error bars indicate SD from mean values.See also [Tables S3](#mmc4){ref-type="supplementary-material"}, [S4](#mmc5){ref-type="supplementary-material"}, and [S5](#mmc6){ref-type="supplementary-material"} and [Data S2](#mmc8){ref-type="supplementary-material"}.

Conclusions {#sec2.7}
-----------

Our results show that human-associated *C. glabrata* isolates belong to (at least) seven genetically distinct clades, some of which present levels of genetic diversity comparable to that found in the global *C. albicans* population. In addition, the absence of a strong geographical structure and the deep genetic divergence between the clades suggest a model of ancient geographical differentiation with recent global dispersion, most likely mediated by humans. This recent dispersion has most likely put in contact *C. glabrata* clades that had been separated over a long period of time. Importantly, our results show that this admixture has resulted in genetic exchange between distinct clades. The existence of some form of sexual cycle is also strongly supported by similar patterns of evolutionary constraints in reproduction-related genes in *C. glabrata*, *C. albicans*, and *S. cerevisiae*. Our results are consistent with previous reports of successful mating-type switching in *MTL1* from **a** to alpha, but also reveal frequent illegitimate recombination at the other *MTL* loci. Importantly, the illegitimate recombinations most likely result from cutting of the *HO* endonuclease sites present in *MTL2* and *MTL3*, which are generally not targeted in *S. cerevisiae*. This difference may relate to the conformational or epigenetic status of these genomic regions. Our finding of an excess of non-synonymous variation of the *C. glabrata* ortholog of *ESC1*, encoding a protein that participates in telomere silencing, may provide the first clue to this fundamental difference, as a functional shift in this protein may have directly impacted the structural or epigenetic organization of *C. glabrata* telomeres and subtelomeric regions.

We report extensive phenotypic and genetic variation, even between closely related strains, indicating fast evolutionary dynamics and a potential for fast adaptation in *C. glabrata*. Genetic variation particularly affects cell-wall proteins involved in adhesion. A species-specific increase in adhesins has been purported as a key step in the emergence of the ability to infect humans in the *C. glabrata* lineage \[[@bib3]\]. Our finding of a highly dynamic genetic repertoire of adhesins and large differences in adhesion capabilities suggests that there is a large degree of standing variation of this trait, which may be the subject of ongoing directional selection. Most of these genes are encoded in subtelomeric regions. The above-mentioned difference in *ESC1* could also be related to such dynamism. Indeed, null mutants of *S. cerevisiae ESC1* show higher chromosome instability and increased transposition of transposable elements. Thus, it is tempting to speculate that a functional shift in *ESC1* may have impacted both mating-type switching and the dynamics of subtelomeric genes, and could also be related to the plasticity of chromosomal structure in *C. glabrata*.

STAR★Methods {#sec3}
============

Key Resources Table {#sec3.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Chemicals, Peptides, and Recombinant Proteins**Penicillin / Streptomycin solutionTHERMO FISHER SCIENTIFIC, S.L.U.15070063Chloroform-isoamylalcohol (24:1)Sigma-AldrichC0549-1PTIsopropanolMerckLOT0476145EthanolSIGMA-ALDRICH QUIMICA S.L51976-500ML-FRibonuclease A from bovine pancreasSIGMA-ALDRICH QUIMICA S.LR6513-10MGT4 DNA polymeraseNew England BiolabsM0201LdATPNew England BiolabsN0440S3′-5′-exo- Klenow fragmentNew England BiolabsM0212LT4 DNA ligaseNew England BiolabsM0202LPhusion DNA polymeraseFinnzymesF530SdNTPsThis studyR0181Hydrogen PeroxideSIGMA-ALDRICH QUIMICA S.L.16911-250ML-FDithiothreitolLIFE TECHNOLOGIES S.A.R08610.1% (w/v) crystal violetFisher Scientific2479-4Sodium dodecyl sulfate 10% SDS, 100 mLSIGMA-ALDRICH QUIMICA S.L.71736-100MLSabouraud agar platesOxoidPO0410FluconazoleSIGMA-ALDRICH QUIMICA S.L.F8929-100MGIsavuconazoleCLINISCIENCES SLA15783-2PosaconazoleSIGMA-ALDRICH QUIMICA S.L.32103-25MGVoriconazoleSIGMA-ALDRICH QUIMICA S.L.PZ0005-5MGMicafunginMOLPORTMolPort-035-789-689CaspofunginSIGMA-ALDRICH QUIMICA S.L.SML0425-5MG5-FluorcytosineSIGMA-ALDRICH QUIMICA S.L.F7129-1GAmphotericin BSIGMA-ALDRICH QUIMICA S.LA4888-100MGMethanol (Reag. Ph. Eur.) for analysis, ACS, ISOPANREAC QUIMICA SLU1310911211D-(+)-Glucose anhydrous, free-flowing, Redi-Dri, ≥ 99.5%SIGMA-ALDRICH QUIMICA S.L.RDD016-1KGMOPS ≥ 99.5% (titration), 250 gSIGMA-ALDRICH QUIMICA S.L.M1254-250GAntibiotic Broth for microbiology (AM 3)SIGMA-ALDRICH QUIMICA S.L.70184-500GRPMI-1640 Medium With L-glutamine, without sodium bicarbonate, powder, suitable for cell cultureSIGMA-ALDRICH QUIMICA S.L.R6504-10LAgaroseCultek, SLH350000Ethidium BromideThermoFisher Scientific15585011Glass beadsSIGMA-ALDRICH QUIMICA S.L.G8772-100G**Critical Commercial Assays**QIAquick PCR purification kitQIAGEN50928106MinElute spin columnsQIAGEN28004MasterPure Yeast DNA Purification KitEPICENTREMPY80200Pfu DNA polymerasePROMEGAM7745**Deposited Data**Sequence dataThis studyPRJNA361477Sequence data\[[@bib20]\]PRJNA222546Sequence data\[[@bib21]\]PRJNA310957Sequence data\[[@bib22]\]PRJNA297263**Experimental Models: Organisms/Strains***Candida glabrata* BG2This studyBG2*Candida glabrata* CST34This studyCST34*Candida glabrata* CST35This studyCST35*Candida glabrata* E1114This studyE1114*Candida glabrata* EB0911StoThis studyEB0911Sto*Candida glabrata* EF0616Blo1This studyEF0616Blo1*Candida glabrata* EF1237Blo1This studyEF1237Blo1*Candida glabrata* EF1620StoThis studyEF1620Sto*Candida glabrata* EI1815Blo1This studyEI1815Blo1*Candida glabrata* EG01004StoThis studyEG01004Sto*Candida glabrata* F03013This studyF03013*Candida glabrata* F11This studyF11*Candida glabrata* F15021This studyF15021*Candida glabrata* F15This studyF15*Candida glabrata* M17This studyM17*Candida glabrata* P35_2This studyP35_2*Candida glabrata* P35_3This studyP35_3*Candida glabrata* B1012MThis studyB1012M*Candida glabrata* B1012SThis studyB1012S*Candida glabrata* BO101SThis studyBO101S*Candida glabrata* CST109This studyCST109*Candida glabrata* CST110This studyCST110*Candida glabrata* CST78This studyCST78*Candida glabrata* CST80This studyCST80*Candida glabrata* EB101MThis studyEB101M*Candida glabrata* F1019This studyF1019*Candida glabrata* F1822This studyF1822*Candida glabrata* F2229This studyF2229*Candida glabrata* I1718This studyI1718*Candida glabrata* M12This studyM12*Candida glabrata* M6This studyM6*Candida glabrata* M7This studyM7*Candida glabrata* reference genome CBS138\[[@bib19]\]CBS138**Oligonucleotides**FWD1: TTGGTCTGTTCCTGAGCCGGSIGMA-ALDRICH QUIMICA S.L.N/AFWD2: ACGAACTGGATAGCACCTCCSIGMA-ALDRICH QUIMICA S.L.N/AFWD3: ATACTGTGACCTTCCCTGTTSIGMA-ALDRICH QUIMICA S.L.N/AREV1: CTCAGCATTGGCAGTAGTGGSIGMA-ALDRICH QUIMICA S.L.N/AREV2: CTTCGCTCCGTGGGTAAACASIGMA-ALDRICH QUIMICA S.L.N/AREV3: CTTCAGATTGGCAGTGTCGGSIGMA-ALDRICH QUIMICA S.L.N/AMTL1_Forward: CGGTCTGATGGTGCAATTGTSIGMA-ALDRICH QUIMICA S.L.N/AMTL1_Reverse: TTGAGTCAAGTGTCGAGGCTSIGMA-ALDRICH QUIMICA S.L.N/AMTL2_Forward: GCTCTTCACTCAACGTACTCCSIGMA-ALDRICH QUIMICA S.L.N/AMTL2_Reverse: TTTACAAACCCACACCGAGGSIGMA-ALDRICH QUIMICA S.L.N/AMTL3_Forward: GTGAGCACTTTGGACCTTCASIGMA-ALDRICH QUIMICA S.L.N/AMTL3_reverse: ACCATAGTCAGACCACCGACSIGMA-ALDRICH QUIMICA S.L.N/A**Software and Algorithms**Trimmomatic v0.36\[[@bib34]\]<http://www.usadellab.org/cms/?page=trimmomatic>SOAPdenovo2 r240\[[@bib35]\]<https://github.com/aquaskyline/SOAPdenovo2>SPAdes v3.1.1\[[@bib36]\]<http://bioinf.spbau.ru/spades>AUGUSTUS v3.2.3\[[@bib37]\]<http://bioinf.uni-greifswald.de/augustus/>OrthoMCL v2.0.9\[[@bib38]\]<http://orthomcl.org>BWA 0.7.12\[[@bib39]\]<http://bio-bwa.sourceforge.net/>Wgsim, v0.3.1N/A<https://github.com/lh3/wgsim>GATK v3.3\[[@bib40], [@bib41], [@bib42]\]<https://software.broadinstitute.org/gatk/>SAMtools\[[@bib43], [@bib44]\]<http://samtools.sourceforge.net/>LDhat v2.2\[[@bib45]\]<http://ldhat.sourceforge.net/>fastGEAR\[[@bib46]\]<https://mostowylab.com/2017/02/26/fastgear/>RDP4 v4.15\[[@bib47], [@bib48]\][http://web.cbio.uct.ac.za/∼darren/rdp.html](http://web.cbio.uct.ac.za/%7Edarren/rdp.html){#intref0065}SplitTree v4\[[@bib49]\]<http://www.splitstree.org/>Mauve v2.4.0\[[@bib50]\]<http://darlinglab.org/mauve/mauve.html>BlastN\[[@bib51]\]<https://blast.ncbi.nlm.nih.gov/>Mugsy v1.2.3\[[@bib52]\]<http://mugsy.sourceforge.net/>TrimAl v.1.4\[[@bib53]\]<https://github.com/scapella/trimal>RAxML v7.3.5\[[@bib54]\]<https://sco.h-its.org/exelixis/web/software/raxml/>STRUCTURE v2.3.4\[[@bib55]\]<https://web.stanford.edu/group/pritchardlab/structure.html>PopGenome, R package\[[@bib56]\]<https://CRAN.R-project.org/package=PopGenome>Growthcurver v0.2.1, R package\[[@bib57]\]<https://CRAN.R-project.org/package=growthcurver>ggplot2, R package\[[@bib58]\]<https://CRAN.R-project.org/package=ggplot2>ade4, R package\[[@bib59]\]<https://CRAN.R-project.org/package=ade4>**Other**dbSNPNCBI<https://www.ncbi.nlm.nih.gov/SNP/>MICROPLATE, 96 WELL, PS, F-BOTTOM, CLEAR, STERILE, 2 PCS./BAGGreiner Bio-One North America655161LID, PS, HIGH PROFILE (9 MM), CLEAR, STERILEGreiner Bio-One North America656161

Contact for Resource Sharing {#sec3.2}
----------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Toni Gabaldón (<toni.gabaldon@crg.eu>).

Experimental Model and Subject Details {#sec3.3}
--------------------------------------

### Strains {#sec3.3.1}

The collection of 33 *C. glabrata* strains used for the analyses in this study are listed in [Table 1](#tbl1){ref-type="table"}. Additional 20 *C. glabrata* strains were obtained at short read archive under accession PRJNA222546, PRJNA310957 and PRJNA297263 \[[@bib20], [@bib21], [@bib22]\].

### DNA extraction {#sec3.3.2}

*C. glabrata* cultures were grown overnight in an orbital shaker (200 rpm, 30°C) in 2 mL YPD (Yeast Peptone Dextrose) medium (0.5% yeast extract, 1% peptone, 1% glucose) supplemented with 1% penicillin- streptomycin solution (Sigma). Subsequently, cells were centrifuged (3000 rpm, 5 min) and washed twice with 1x sterile PBS. The pellet was resuspended in 500 μL lysis buffer (1 w/V% SDS, 50mM EDTA, 100 mM TRIS pH = 8), afterward 500 μL of glass beads were added to the cells which then were disrupted by using a vortex for 3 min. 275 μL 7M ammonium-acetate were added (65°C, 5 min) and the samples were cooled on ice for 5 min. Then 500 μL of chloroform-isoamylalcohol (24:1) were added to the mixture, which was then centrifuged for 10 min at 13000 rpm. The upper phase of the solution was transferred to a new microcentrifuge tube, and the previous step was repeated. 500 μL isopropanol was mixed with the upper phase of the solution in a new microcentrifuge tube, and the mixture was held in a refrigerator at −20°C for 5 min. The solution was centrifuged at 13000 rpm for 10 min. The supernatant was discarded, and the pellet was washed twice with 500 μL 70% ethanol. After the second washing step the pellet was dried and resuspended in 100 μL bi-distilled water containing RNase (Sigma).

Method Details {#sec3.4}
--------------

### Sequencing {#sec3.4.1}

The genome sequences for all the strains were obtained at the Ultra-sequencing core facility of the CRG, using Illumina HiSeq2000 sequencing machines. Paired-end libraries were prepared. For this, DNA was fragmented by nebulization or in Covaris to a size of ∼600 bp. After shearing, the ends of the DNA fragments were blunted with T4 DNA polymerase and Klenow fragment (New England Biolabs). DNA was purified with a QIAquick PCR purification kit (QIAGEN). 3′-adenylation was performed by incubation with dATP and 3′-5′-exo- Klenow fragment (New England Biolabs). DNA was purified using MinElute spin columns (QIAGEN) and double-stranded Illumina paired-end adapters were ligated to the DNA using rapid T4 DNA ligase (New England Biolabs). After another purification step, adaptor-ligated fragments were enriched, and adapters were extended by selective amplification in an 18-cycle PCR reaction using Phusion DNA polymerase (Finnzymes). Libraries were quantified and loaded into Illumina flow-cells at concentrations of 7--20 pM. Cluster generation was performed in an Illumina cluster station. Sequence runs of 2x100 cycles were performed on the sequencing instrument. Base calling was performed using Illumina pipeline software. In multiplexed libraries, we used 4 bp internal indexes (5′ indexed sequences). De-convolution was performed using the CASAVA software (Illumina). All sequence data has been deposited in SRA and will be available upon publication.

### Genome assembly {#sec3.4.2}

Reads were pre-processed previous to assembly to trim at the first undetermined base or at the first base having PHRED quality below 10 using Trimmomatic v0.36 \[[@bib32]\]. The pairs with reads shorter than 31 bases after trimming were not included from the assembly process. SOAPdenovo2 \[[@bib35]\] and SPAdes v3.1.1 \[[@bib36]\] with default parameters was used to assemble paired-ends reads into chromosomes. AUGUSTUS software \[[@bib37]\] was used to predict genes and after that, were clustered based on gene similarity using orthoMCL software \[[@bib38]\] in order to obtain core genome analysis. Strains CST34, CST35, M17 and F2229 were removed from the analysis because of the low quality of the raw reads.

### SNP calling {#sec3.4.3}

Reads were aligned onto the reference assembly of the CBS138 strain \[[@bib19]\]þusing BWA, with the BWA-MEM algorithm with 16 as number of threads \[[@bib39]\]. As no raw reads are publicly available for the recently-sequenced pyruvate-producing strain *C. glabrata* CCTCC M202019 \[[@bib20]\], the Wgsim software v0.3.1-r13 (<https://github.com/lh3/wgsim>) was used to simulate reads from the assembled genome sequence using defaults parameters, except for the rate of mutations and fraction of indels that was set to 0 and number of read pairs that was set to 100000000.

We identified SNPs using GATK v3.3 \[[@bib40], [@bib41], [@bib42]\]þwith an haploid model, filtering out clusters of 5 variants within 20 bases and low quality variants, and using thresholds for mapping quality and read depth (\> 40 and \> 30 respectively). To confirm ploidy levels and assess heterozygosity in duplicated chromosomes we repeated the SNP calling analysis enforcing a diploid model. Thereafter, variants were divided into homozygous and heterozygous categories.

### Structural variants {#sec3.4.4}

To detect structural variants we used deviations from the expected depth of coverage. Calling deletions or duplications at genomic regions with variable coverage is a widely accepted methodology \[[@bib60]\]. For every C. *glabrata* strain we calculated the number of genes deleted and duplicated using depth of coverage analysis from Samtools \[[@bib43], [@bib44]\]. After mapping the reads of each strain to the reference genome a gene was considered missing in the strain if less than 90% of the length of a given gene was covered by reads. For duplications and large scale structural variants, we normalized the number of reads per gene and a duplication was called if the median coverage of that gene was 1.8 times or higher than the median coverage of the chromosome. All these structural variants were manually curated and one deletion comprising three genes was validated experimentally (see below).

### Experimental validation of CNVs {#sec3.4.5}

The deletion of a region comprising three genes (corresponding to deletion numbers 33, 34 and 35 ([Data S1](#mmc7){ref-type="supplementary-material"}) was experimentally confirmed by means of PCR and Sanger sequencing in the following strains: EF1620Sto, F11, F15, EG01004Sto, F03013, F15021 and CBS138. Because the investigated fragment was 8,134 base pairs long, four different sets of primers were designed to be able to capture the whole fragment ([Figure S4](#mmc1){ref-type="supplementary-material"}A). First PCRs were performed with CBS138 (control strain) and one of the investigated strains (EF1620Sto) and primers FWD1:REV1, FWD2:REV2, FWD3:REV3 to validate the absence of the deletion in the control strain and the feasibility of the primers and PCR reactions ([Figure S4](#mmc1){ref-type="supplementary-material"}B). In this case amplicons from the three primer pairs are expected only in the control strain. Then the absence of the fragment was tested with the results of the PCR with FWD1:REV3 ([Figure S4](#mmc1){ref-type="supplementary-material"}C). With this primer, the absence of a band in the CBS138 control strain indicates that the deletion is not present, and the amplification of a fragment of approximately 2 kbp long in the other strains confirms the existence of the deletion. DNA extraction was performed with the MasterPure Yeast DNA Purification Kit from EPICENTRE according to the manufacturer's protocol. PCRs were carried out by using *Pfu* DNA polymerase from PROMEGA. The reaction mixture included primer concentration of 0.4 μM, 5 μL of *Pfu* polymerase 10X buffer with MgSO~4~, 200 μM of dNTPs each, 1.2 U of *Pfu* DNA polymerase, 100 ng of DNA and water up to a final volume of 50 μL. Standard PCR protocol was used for primers: FWD1:REV1, FWD3:REV3 and FWD1:REV3. Here, initial denaturation was performed at 95°C for 2min, followed by 30 cycles of 30 s at 92°C, 30 s at either 60.3°C (FWD1:REV1), 59.3°C (FWD3:REV3) or 60.3°C (FWD1:REV3); 190 s (FWD1:REV1) or 120 s (FWD3:REV3) or 220 s (FWD1:REV3) at 72°C. It was finished with final extension for 5 min at 72°C and cooled to 4°C. The touchdown PCR was performed for FWD2:REV2. Cycling condition began with 2 min at 95°C, followed by 15 cycles of 30 s at 95°C, 15 s at the annealing temperature of 61.3°C (decreasing 0.5°C each cycle) and 4 min 20 s at 72°C. Then, other 20 cycles of 30 s at 95°C, 15 s at the annealing temperature of 54.3°C and 4 min 20 s at 72°C were set up, with a final extension step at 72°C for 5 min. All PCR products were visualized by 1% agarose gel electrophoresis ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C) and were then purified using the QIAquick PCR Purification Kit (QIAGEN) for subsequent Sanger sequencing. Sequences of the primers used (5′- \> 3′) were: FWD1: TTGGTCTGTTCCTGAGCCGG; FWD2: ACGAACTGGATAGCACCTCC, FWD3: ATACTGTGACCTTCCCTGTT; REV1: CTCAGCATTGGCAGTAGTGG; REV2: CTTCGCTCCGTGGGTAAACA and REV3: CTTCAGATTGGCAGTGTCGG.

### PCR amplification of mating-type regions and sequencing {#sec3.4.6}

In order to validate mating-type switching in *C. glabrata*, we performed Sanger sequencing of the three different loci *MTL1*, *MTL2* and *MTL3* encoding for the two **a** and alpha mating types in 14 different strains: E1114, M6, CST110, EG01004Sto, F15021, F03013, BG2, P35_2, P35_3, M12, EI1815Blo, F11, EF1237Blo1 and the reference CBS138. DNA extraction and PCRs were performed as indicated in the previous section. Primers used (5′- \> 3′) and expected amplicon sizes (bp) are as follows: MTL1_Forward: CGGTCTGATGGTGCAATTGT, MTL1_Reverse: TTGAGTCAAGTGTCGAGGCT (1760 bp); MTL2_Forward: GCTCTTCACTCAACGTACTCC, MTL2_Reverse: TTTACAAACCCACACCGAGG (1305 bp); MTL3_Forward: GTGAGCACTTTGGACCTTCA, MTL3_reverse: ACCATAGTCAGACCACCGAC (1908 bp). Briefly, each reaction included primer concentration of 0.4 μM, 5 μL of *Pfu* polymerase 10X buffer with MgSO~4~, 200 μM of dNTPs each, 1.2 U of *Pfu* DNA polymerase, 100 ng of DNA and water up to a final volume of 50 μL. Cycling condition began with a warm-up step of 2 min at 95°C, followed by 30 cycles of 30 s at 95°C, 30 s at the corresponding annealing temperature (55.5°C, 58.4°C and 58.3°C for *MTL1*, *MTL2* and *MTL3*, respectively) and an elongation step at 72°C for 3 min 50 s, 2 min 20 s, and 3 min 20 s for *MTL1*, *MTL2* and *MTL3*, respectively, with a final elongation step of 72°C for 5 min. PCR products were confirmed by 1.5% agarose gel electrophoresis, were then purified using QIAquick PCR purification kit according to manufacturer's instructions (QIAGEN) and finally sequenced with Sanger using the same set of primers.

### Recombination estimates {#sec3.4.7}

We used the interval program implemented in the LDhat v2.2 package \[[@bib45]\] to estimate population-scale recombination rates for each chromosome separately. The program was executed for 5 million iterations with sampling every 2500 iterations as recommended in the user manual. The output of interval was summarized using stats software from LDhat v2.2 as indicated by the authors. The amount of ancestral and recent recombination for all chromosomes was estimated using fastGEAR software \[[@bib46]\] using default parameters. To specifically estimate recombination in the deleted regions and nearby, we used a two-steps pipeline. First, we select deletions that appeared in more than one clade. Second, for each selected deletion we extracted genomic regions located 1Kb up- and downstream of the affected gene. Then, we used RDP4 v4.15 \[[@bib47], [@bib48]\] to identify footprints of homologous recombination, and to produce recombination rate plots \[[@bib61]\]. Finally, we used SplitTree v4 \[[@bib49]\] to reconstruct phylogenetic networks and to detect gene flow.

### Chromosomal rearrangements {#sec3.4.8}

We identified the presence of chromosomal arrangements using two steps. First, we obtained *de novo* assemblies of all genome from the 32 *C. glabrata* strains. Second, we reordered them using CBS138 as a reference applying Mauve Contig Mover from Mauve \[[@bib50]\]. Final contigs with rearrangements were confirmed using BlastN \[[@bib51]\]

### Phylogenetic analysis {#sec3.4.9}

We reconstructed a species tree including the 32 sequenced *Candida glabrata* strains, the reference strain CBS138 and *Candida bracarensis* (CBS10154) \[[@bib3]\] as the outgroup. By using the previously annotated SNPs for the 32 strains, we reconstructed the sequence of each strain by replacing the reference nucleotide for a given SNP. Then, these 34 genomes were aligned using Mugsy v1.2.3 \[[@bib52]\]. The resulting alignment was trimmed using TrimAl v.1.4 \[[@bib53]\]þto delete positions with more than 50% gaps. Finally, a phylogenetic tree was reconstructed from the trimmed alignment using RAxML v7.3.5, model Protgammalg \[[@bib54]\].

For comparison with the phylogenetic tree based in MLST, we used the MLST sequences from the 32 sequenced strains and the reference CBS138. Following the same steps, we reconstructed the sequences of each strain by replacing the reference nucleotide for a given SNP, then we replaced nucleotides with a coverage lower than 30 with gaps. Finally, the final sequences were aligned and trimmed using Mugsy v1.2.3 and TrimAl v.1.4 respectively. The final phylogenetic tree was reconstructed using RAxML v7.3.5 as used during the whole genome tree.

### Population Genomics {#sec3.4.10}

We used the software STRUCTURE v2.3.4 to study the genetic structure of the population \[[@bib55]\]. In addition, we used popGenome to estimate F~ST~ between different clades \[[@bib56]\]. We recorded the number of SNPs in *C. glabrata* population using the 33 strains. We obtained the number of SNP also using 32 different strains from *C. albicans,* as indicated above for *C. glabrata,* and we obtained SNP data from *Saccharomyces cerevisiae* using dbSNP \[[@bib62]\]þas of October 2015. We calculated the ratio of non-synonymous and synonymous nucleotide diversity (π~N~/π~S~) assuming that ¾ of all sites are non-synonymous, and ¼ synonymous.

### Phenotypic analyses: Growth curves {#sec3.4.11}

Each strain was recovered from our glycerol stock collection and grown for 2 days at 37°C on a YPD agar plate. First, single colonies were cultivated in 15 mL YPD medium in an orbital shaker (37°C, 200 rpm, overnight). Second, each sample was diluted to an optical density (OD) at 600 nm of 0.2 in 3 mL of YPD medium and grown for 3 h more in the same conditions (37°C, 200 rpm). Then, dilutions were made again to have an OD at 600 nm of 0.5 in 1 mL of YPD medium in order to start all the experiments with approximately the same amount of cells. The samples were centrifuged for 2 min at 3000 g, washed with 1 mL of sterile water, and centrifuged again for 2 min at 3000 g for a final resuspension of the pellet in 1 mL of sterile water. Finally, 5 μL of each sample was inoculated in 95 μL of the corresponding medium in a 96-well plate. All experiments were run in triplicate.

A total of six different growth conditions were tested: the oxidative stress was assessed by the growth of the cultures on YPD medium supplemented with 10 mM H~2~O~2~, reductive stress with 2.5 mM DTT and osmotic stress with 1 M NaCl. We also measured the impact of elevated temperature (41.5°C), pH = 2 and pH = 9 along with the control growth on YPD itself. Cultures were grown in 96-well plates at 37°C or 41.5°C, shaking, for 24 or 72 h depending on the growth rate in each condition, and monitored to determine the optical density at 600 nm every ten min by a TECAN Infinite M200microplate reader. Finally, results from growth conditions were analyzed using an R package called Growthcurver v0.2.1 \[[@bib57]\].

### Phenotypic analyses: biofilm formation assay {#sec3.4.12}

The capacity to form biofilms was assayed as described previously \[[@bib30]\]. Briefly, studied isolates and controls (CBS138, moderate biofilm formation capacity; PEU-382 and PEU-427, high biofilm formation capacity were cultured overnight in YPD medium at 37°C. The optical density was determined at 600 nm (Ultrospec 1000) and adjusted to a value of 2 using sterile NaCl~physiol~. 50 μL aliquots of the cell suspensions were placed into 96-well polystyrol microtiter plates (Greiner Bio-one) and incubated for 24 h at 37°C. The medium was removed and the attached biofilms washed once with 200 μL distilled water. Cells were stained for 30 min in 100 μL of 0.1% (w/v) crystal violet (CV) solution. Excess CV was removed and the biofilm carefully washed once with 200 μL distilled water. To release CV from the cells, 200 μL 1% (w/v) SDS in 50% (v/v) ethanol were added and the cellular material resuspended by pipetting. CV absorbance was quantified at 490 nm using a microtiter plate reader (MRX TC Revelation). The data shown is the average of three independent biological experiments, each including four technical repeats.

### Antifungal drug susceptibility testing {#sec3.4.13}

Prior to analysis, the isolates were cultured overnight on Sabouraud (Oxoid) agar plates. Antifungal drug susceptibilities toward Fluconazole, Isavuconazole, Posaconazole, Voriconazole, Micafungin, Caspofungin, 5-Fluorcytosine, and Amphotericin B were determined according to EUCAST EDef 7.1 method \[[@bib63]\]. The MIC values of each isolates were calculated according to EUCAST guidelines (<http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Clinical_breakpoints/Antifungal_breakpoints_v_8.0_November_2015.xlsx>, accessed Nov 16^th^ 2016)

### Pulsed-field gel electrophoresis {#sec3.4.14}

Intact chromosomes were separated using pulsed-field gel electrophoresis (PFGE) as described before \[[@bib25]\]. To better visualize differences between small chromosomes (size range CBS 138 ChrA-K) conditions were modified to using 1.2% agarose at 17°C and pulse times from 40-100 s. Large chromosomes (size range CBS138 ChrK-M) were resolved with pulse times form 60-140 s.

Quantification and Statistical Analysis {#sec3.5}
---------------------------------------

All statistical details (statistical test used, number of samples, and p values) for each experiment can be found in the text and in the Figure labels.

Fisher tests were computed using R and plots were obtained using the ggplot2 package for R \[[@bib58]\]. Multiple Correspondence Analysis (MCA) was performed using ade4 package for R to establish the main relationships between all sequenced strains and the reference \[[@bib59]\]. MCA is a technique similar to principal component analysis (PCA) but specific for nominal categorical data, which is used to detect and represent underlying structures in datasets. Principal Component Analysis (PCA) was used to understand the relationship between the analysis from the growth curves and the distribution of our genomes using stats package for R.

Data and Software Availability {#sec3.6}
------------------------------

Sequence data produced for this project has been deposited at short read archive under the accession PRJNA361477.

Supplemental Information {#app2}
========================

Document S1. Figures S1--S7Table S1. Information about the 32 Strains of *C. albicans* Re-analyzed in This Study, Related to Figure 5Columns indicate, in this order: strain name or ID; host; isolation site; country of isolation; mating type (if any); experiment name in short read archive (SRA); number of SRA run.Table S2. Synonymous versus Non-synonymous Variation per Gene, Related to Figure 5The first column indicates the gene functional category (based on their function in *S. cerevisiae*). The following columns indicate gene ID, gene name (only for *S. cerevisiae*), and π~N~/π~S~ for *C. glabrata*, *C. albicans*, and *S. cerevisiae* genes*.*Table S3. Growth Curve Values from Phenotype Analysis, Related to Figure 6Columns indicate, in this order: condition used for the analysis; sample; clade; carrying capacity (K); population size at time 0 (n0); growth rate (r); time when the population density reaches ½K (t_mid); fastest possible generation time (t_gen); area under the logistic curve measured by taking the integral of the logistic equation (auc_l); empirical area under the curve (auc_e); measure of the goodness of fit of the parameters for the logistic equation (a small value indicates a better fit of the curve) (sigma).Table S4. Antifungal Sensitivity, Related to Figure 6Range of sensitivity levels (triplicate experiments) to amphotericin B (MIC~90~), 5-fluorocytosine, fluconazole, voriconazole, posaconazole, isavuconazole, micafungin, and caspofungin (all MIC~50~) and, where available (<http://www.eucast.org/clinical_breakpoints>), classification according to clinical breakpoints. S, sensitive; I, intermediate; R, resistant. Red and boldfaced names and values indicate isolates with minimal inhibitory concentration (MIC) values measured deviating from the wild-type distribution. There are no species-specific clinical breakpoints available for 5-fluorocytosine (5FC), voriconazole, posaconazole, isavuconazole, or caspofungin. The measured MIC range in most isolates (three technical repeats) encompasses both "susceptible" and "resistant" interpretations according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint definition: S ≤ 0.032, R \> 0.032 for micafungin.Table S5. Levels of Nucleotide Variation per Strain and Mutations in *MSH2*, Related to Figure 6Columns indicate, in this order: strain name; clade; non-synonymous variant; Saccharomycotina species presenting the same non-synonymous mutations (five-letter codes correspond to species mnemonic based on the UniProt taxonomy database \[[@bib33]\]); reduced sensitivity of the strain to any antifungal tested; genome-wide π~N~; genome-wide π~S~; genome-wide π~N~/π~S~.Data S1. Genes Affected by CNVs, Related to Figure 2Columns indicate, in this order: duplication or deletion number in this study (corresponds to Figure 2); gene ID; gene name; name of *S. cerevisiae* one-to-one ortholog (if any); description.Data S2. Private Mutations per Strain, Non-synonymous SNPs and CNVs, Related to Figure 6Columns of private non-synonymous SNPs indicate, in this order: strain ID; chromosome and position affected by the SNP; gene ID; amino acid substitution; gene name; description. The first column based on CNV indicates the strain analyzed. The following columns indicate the gene affected and description of gene affected.Document S2. Article plus Supplemental Information
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[^1]: Lead Contact

[^2]: Columns indicate, in this order: strain name or ID; synonym (if any); mean sequencing coverage (if sequenced in this study); body site of isolation; country of isolation; mating type; CC (clonal complex); RT (repeat type); publication describing the source. NA, not assigned.

[^3]: Commensal strain.
